Kevin Caliendo
Stock Analyst at UBS
(4.03)
# 555
Out of 5,128 analysts
197
Total ratings
64.42%
Success rate
7.41%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $96 → $97 | $79.79 | +21.57% | 11 | Dec 10, 2025 | |
| SOLV Solventum | Maintains: Neutral | $77 → $79 | $84.24 | -6.22% | 2 | Nov 10, 2025 | |
| LFST LifeStance Health Group | Maintains: Buy | $9 → $10 | $7.30 | +36.99% | 6 | Nov 7, 2025 | |
| COR Cencora | Maintains: Buy | $380 → $415 | $340.41 | +21.91% | 4 | Nov 7, 2025 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $4.25 → $4 | $2.85 | +40.35% | 8 | Nov 6, 2025 | |
| MCK McKesson | Maintains: Buy | $920 → $980 | $823.95 | +18.94% | 17 | Nov 6, 2025 | |
| CAH Cardinal Health | Maintains: Buy | $185 → $220 | $207.19 | +6.18% | 18 | Oct 31, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $17 → $18 | $20.93 | -14.00% | 8 | Oct 31, 2025 | |
| UNH UnitedHealth Group | Maintains: Buy | $378 → $430 | $341.70 | +25.84% | 13 | Oct 29, 2025 | |
| LH Labcorp Holdings | Maintains: Buy | $325 → $320 | $253.73 | +26.12% | 7 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $23 | $12.37 | +85.93% | 12 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $176.38 | -3.62% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $190 | $178.14 | +6.66% | 16 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $160 → $155 | $166.81 | -7.08% | 19 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $70 | $78.14 | -10.42% | 6 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $18 → $22 | $22.93 | -4.06% | 4 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $4.15 | +261.45% | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $9 | $5.16 | +74.42% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $279.12 | +39.72% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $275.06 | -9.11% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $45.77 | +72.60% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $366.69 | +56.81% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $207.49 | -13.25% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $7.57 | +851.12% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $32.40 | -66.05% | 4 | May 4, 2021 |
CVS Health
Dec 10, 2025
Maintains: Buy
Price Target: $96 → $97
Current: $79.79
Upside: +21.57%
Solventum
Nov 10, 2025
Maintains: Neutral
Price Target: $77 → $79
Current: $84.24
Upside: -6.22%
LifeStance Health Group
Nov 7, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $7.30
Upside: +36.99%
Cencora
Nov 7, 2025
Maintains: Buy
Price Target: $380 → $415
Current: $340.41
Upside: +21.91%
GoodRx Holdings
Nov 6, 2025
Maintains: Neutral
Price Target: $4.25 → $4
Current: $2.85
Upside: +40.35%
McKesson
Nov 6, 2025
Maintains: Buy
Price Target: $920 → $980
Current: $823.95
Upside: +18.94%
Cardinal Health
Oct 31, 2025
Maintains: Buy
Price Target: $185 → $220
Current: $207.19
Upside: +6.18%
Alignment Healthcare
Oct 31, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $20.93
Upside: -14.00%
UnitedHealth Group
Oct 29, 2025
Maintains: Buy
Price Target: $378 → $430
Current: $341.70
Upside: +25.84%
Labcorp Holdings
Oct 29, 2025
Maintains: Buy
Price Target: $325 → $320
Current: $253.73
Upside: +26.12%
Oct 28, 2025
Maintains: Buy
Price Target: $24 → $23
Current: $12.37
Upside: +85.93%
Oct 24, 2025
Maintains: Neutral
Price Target: $180 → $170
Current: $176.38
Upside: -3.62%
Oct 17, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $178.14
Upside: +6.66%
Oct 16, 2025
Maintains: Neutral
Price Target: $160 → $155
Current: $166.81
Upside: -7.08%
Aug 6, 2025
Maintains: Neutral
Price Target: $75 → $70
Current: $78.14
Upside: -10.42%
Jul 29, 2025
Maintains: Neutral
Price Target: $18 → $22
Current: $22.93
Upside: -4.06%
May 9, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $4.15
Upside: +261.45%
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $5.16
Upside: +74.42%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $279.12
Upside: +39.72%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $275.06
Upside: -9.11%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $45.77
Upside: +72.60%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $366.69
Upside: +56.81%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $207.49
Upside: -13.25%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $7.57
Upside: +851.12%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $32.40
Upside: -66.05%